drugset
drugset / Trial / NCT01222871

Treatment of Early Nasal Polyposis With Topical Triamcinolone

NCT01222871 ↗

Phase 1/2 Terminated 1 enrolled Steward St. Elizabeth's Medical Center of Boston, Inc.
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.

Timeline

Start
2010-07
Primary completion
2012-07
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Other / unclassified — Intranasal

Indications

nasal cavity polyp